The lowest price of the product zł449.00 in day 07.01.2026
Radiesse Lidocaine is a sterile, non-pyrogenic, semi-solid Class III medical device in the form of an implantable gel. It consists of synthetic calcium hydroxylapatite (CaHA) microspheres with a diameter of 25–45 microns, suspended in a water-based gel carrier, with the addition of 0.3% lidocaine hydrochloride to reduce pain discomfort during application. The device is fully biocompatible, serving as a mechanical volumetric implant and a biostimulator of neocollagenesis, undergoing slow enzymatic degradation.
mechanism of action
immediate mechanical correction: directly after implantation, the gel matrix provides a physical filling effect and restores soft tissue volume
induction of neocollagenesis (biostimulation): the CaHA microspheres create a scaffold within the subcutaneous tissue and dermis, which induces mechanical stimulation of fibroblasts to produce endogenous type I collagen
progressive tissue restructuring: as the gel carrier is physiologically resorbed (after approx. 4 months), the implant site is replaced by a newly formed network of collagen fibers, resulting in long-term increases in skin density and elasticity
anesthetic action: the lidocaine content inhibits the conduction of pain impulses at the injection site, improving the patient's tolerance profile for the procedure
high tissue stability: due to the precise size range of the microspheres (25-45 microns), the device minimizes the risk of migration and foreign body reactions
indications and intended use
The device is intended for deep implantation (subcutaneous or supraperiosteal) by authorized medical personnel for:
volumetry and contour modeling: correction of the jawline, zygomatic bones, and modeling the shape of the chin and nose
treatment of atrophy and volume loss: filling of sunken cheeks, temples, nasolabial folds, and marionette lines
restructuring of tissue laxity: improvement of skin density in the middle and lower thirds of the face and on the earlobes
revitalization of the dorsal surface of the hands: mechanical reduction of the visibility of veins and tendons by increasing subcutaneous tissue volume
composition
Synthetic Calcium Hydroxylapatite (CaHA): microspheres of uniform size (25-45 microns)
Lidocaine Hydrochloride: 0.3% (ancillary substance with local anesthetic action)
Gel Carrier: water for injection, glycerin, sodium carboxymethylcellulose, sodium buffer
technical information
form: ready-to-use pre-filled syringe with viscoelastic gel containing an anesthetic agent
application site: deep dermal layer, subcutaneous tissue, or supraperiosteal
injection parameters: recommended 28G ¾ (0.36 x 19 mm) needles or cannulas of appropriate caliber
duration of implantation: clinical effects resulting from collagen remodeling typically last up to 18 months
volume: 1.5 ml
package contents: 1 pre-filled syringe, 2 needles (28G ¾)
 |
PRE-FILLED SYRINGE |
|
 |
The product may only be used by professionals. By making a purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine. |
|
Dear Customer
The online store www.centerfillers.com is intended for professionals, people with education in the field of medicine, aesthetic medicine and for entrepreneurs interested in the store's products in connection with their business activity.
By going to the website www.centerfillers.com, I declare that I am aware that the content on the website is intended only for professionals and I am a person with education in the field of aesthetic medicine, or I am an entrepreneur interested in the offer as part of my business activity.
I confirmLeave this page
Cookies
